Lisa J. States, MD
Professor of Clinical Radiology
Pediatric Radiologist, Pennsylvania Hospital, Philadelphia, PA
Endowed Chair for Molecular Imaging, Children's Hospital of Philadelphia, Philadelphia, PA
Department: Radiology
Contact information
Children's Hospital of Philadelphia
Department of Radiology
3404 Civic Center Boulevard
Philadelphia, PA 19104
Department of Radiology
3404 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-425-7146
Fax: 267-425-7068
Fax: 267-425-7068
Email:
states@email.chop.edu
states@email.chop.edu
Education:
BA (Human Biology)
Stanford University, Stanford, CA, 1985.
MD (Medicine)
Weill Cornell Medical College, New York City, NY, 1989.
Permanent linkBA (Human Biology)
Stanford University, Stanford, CA, 1985.
MD (Medicine)
Weill Cornell Medical College, New York City, NY, 1989.
Description of Research Expertise
Interpretation of 18 FDOPA PET/CT used for the localization of a focal lesion of congenital hyperinsulinism.Sponsor and Principle Investigator. PROTOCOL: Expanded Access 18F-DOPA PET/CT.
Metaiodobenzylguanidine (131 I-MIBG) Therapy for Refractory Neuroblastoma and Paraganglioma/ Pheochromocytoma Expanded access protocol
Thyroid Gland Screening Surveillance in Childhood Cancer Survivors after Radiotherapy
PET/MRI Protocol Optimization. PI.
NEPENTHE Trial. Co-Investigator.
Description of Clinical Expertise
pediatric oncologypediatric nuclear medicine and Molecular Imaging
Pediatric PET/CT scan
Pediatric PET/MRI
Congenital hyperinsulinism imaging with 18FDOPA
musculoskeletal MRI
Description of Other Expertise
MIBG research protocols and therapySelected Publications
States, L: Impact of molecular therapy on radioactive iodine uptake in patients with oncogene-driven metastatic differentiated thyroid cancer. American Society of Clinical Oncology Annual Meeting, Chicago, IL Jun 2024 Notes: Poster.Ami V. Desai, Arlene Naranjo, Brian LaBarre, Kelly C. Goldsmith, Meaghan Granger, Lisa States, Steven DuBois, Rochelle Bagatell, Julie R. Park, Araz Marachelian: A Pilot Study of Post-Consolidation Chemoimmunotherapy for High-Risk Neuroblastoma (ANBL19P1): A Report from the Children’s Oncology Group. American Society of Clinical Oncology Annual Meeting, Chicago, IL May 2024 Notes: Poster.
Thacker PG, Iyer RS, Pace E, States LJ, Guillerman RP: Imaging of pediatric pulmonary tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric Blood and Cancer September 2023 Notes: doi: 10.1002/pbc.29964.
Reynolds, D., Mitteer, L. M., Sigal, W., Boyajian, L., McKnight, H., Bhatti, T., States, L., Becker, S., Adzick, N. S., Lord, K., & De Leon, D. D.: Novel Use of Dasiglucagon, a Soluble Glucagon Analog, for the Treatment of Hyperinsulinemic Hypoglycemia Secondary to Suspected Insulinoma: A Case Report. Hormone research in paediatrics Page: 1-8, July 2023 Notes: DOI: 10.1159/000531251; Online ahead of print as of February 2024.
Eklund MJ, States LJ, Acord MR, Alazraki AL, Behr GG, El-Ali AM, Morin CE, Saigal G, Shet NS, Thacker PG, Trout AT: Imaging of pediatric pancreas tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric Blood Cancer 70(4): Suppl 4: e29975, Jun 2023 Notes: Doi:10.1002/pbc.29975. Epub 2022 Oct 10.
Bojarsky M, Baran JA, Halada S, Isaza A, Zhuang H, States L, Grant FD, Robbins S, Sisko L, Ricarte-Filho JC, Kazahaya K, Adzick NS, Mostoufi-Moab S, Bauer AJ.: Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy. Journal of Clinical Endocrinol Metabolism June 2023 Notes: doi: 10.1210/clinem/dgad322. Epub ahead of print.
Pace E, Johnson TS, Kao SC, Parikh AK, Qi J, Rajderkar DA, Reid JR, Towbin AJ, States LJ: Imaging of pediatric extragonadal pelvic soft tissue tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. Pediatric Blood Cancer Page: Suppl 4:e29966, Jun 2023 Notes: doi:10.1002/pbc.29966. Epub 2022 Dec 8.
Ghosh A, Yekeler E, Teixeira SR, Dalal D, States L.: Role of MRI radiomics for the prediction of MYCN amplification in neuroblastomas. European Radiology May 2023 Notes: doi: 10.1007/s00330-023-09628-7. Epub ahead of print.
Goldsmith KC, Park JR, Kayser K, Malvar J, Chi YY, Groshen SG, Villablanca JG, Krytska K, Lai LM, Acharya PT, Goodarzian F, Pawel B, Shimada H, Ghazarian S, States L, Marshall L, Chesler L, Granger M, Desai AV, Mody R, Morgenstern DA, Shusterman S, Macy ME, Pinto N, Schleiermacher G, Vo K, Thurm HC, Chen J, Liyanage M, Peltz G, Matthay KK, Berko ER, Maris JM, Marachelian A, Mossé YP. : Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Nature Medicine 29(5): 1092-1102, May 2023 Notes: doi: 10.1038/s41591-023-02297-5. Epub 2023 Apr 3.
Nithya Navarathna, Susan Becker, Lisa States: 18F-FDOPA PET Imaging in Congenital Hyperinsulinism for Localization of A Focal Pancreatic Lesion: Do Medications Interfere with Radiotracer Uptake? Hyperinsulinism-Novel Genes, Drugs and Guidelines, Syllabus March 2023 Notes: poster presentation.